HOME >> MEDICINE >> NEWS
NIH launches National Commission on Digestive Diseases

Bethesda, Maryland (Sept. 14, 2005) This week, Director of the National Institutes of Health (NIH) Elias A. Zerhouni, MD, announced the establishment of the National Commission on Digestive Diseases. This is a major victory for patients with digestive diseases and for the AGA, which has worked tirelessly for the creation of the Commission.

Consistent with AGA legislative language included in an appropriations bill signed into law by President Bush last year, NIH and the Department of Health and Human Services (HHS) will develop a Long-Range Plan for Digestive Diseases to focus on the needs of gastroenterologists and their patients.

"The creation of the National Commission on Digestive Diseases is a landmark event in the advancement of the science and practice of gastroenterology," said David A. Peura, MD, AGA president. "Our goal in proposing the Commission was to obtain the funds and focus needed to increase the rate of discovery and to translate advances into clinical practice."

The Commission will assess the state-of-the-science in digestive diseases and the related NIH research portfolio, with a view toward identifying areas of research challenge and opportunity. The Commission's Research Plan will then guide the NIHalong with the investigative and lay communitiesin pursuing important research avenues to combating digestive diseases.

In 1976, Congress created the Commission on Digestive Diseases Research, which proposed a long-term plan and made recommendations that laid the groundwork for significant progress in the area of digestive health. The newly mandated National Commission on Digestive Diseases will update the findings of the original Commission and will be composed of scientists, physicians, patient advocates and representatives of federal agencies.

According to "The Burden of Gastrointestinal Diseases," a study conducted by the AGA in 2001, disorders of the digestive tract comprise a spectrum of gastroin
'"/>

Contact: Kimberly Wise
media@gastro.org
301-941-2620
American Gastroenterological Association
16-Sep-2005


Page: 1 2

Related medicine news :

1. Worlds largest respiratory health study launches next phase
2. Elsevier launches the Clinics on ScienceDirect
3. Elsevier launches Molecular Oncology
4. Kennedy Krieger Institute launches first national online autism registry
5. UW launches study testing adult stem cells for heart damage repair
6. IEEE-USA launches critical infrastructure protection committee
7. Liverpool launches 20 million project to develop medicines for children
8. ESSP launches project on the effects of global environmental change on human health
9. ACP re-launches magazine for hospitalists
10. The Starr Foundation launches multi-institutional cancer consortium
11. Rochester launches Cancer Stem Cell Research Program

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH launches National Commission Digestive Diseases

(Date:11/27/2014)... 2014 HealthPostures, a leading ... , has announced that it has entered into ... The partnership will put HealthPostures' products into central ... In addition to having its products sold through ... HealthPostures' products with the business decision makers in ...
(Date:11/27/2014)... Philadelphia, PA (PRWEB) November 27, 2014 ... alongside volunteer Aria Health employees, prepared and donated ... to the Lutheran Settlement House , a non-profit, ... and families living in Philadelphia. The dinners were ... Settlement House Senior Center, and distributed to vulnerable ...
(Date:11/27/2014)... November 27, 2014 Allowing children to help ... during school, helps give children responsibility, ownership, boosts self-esteem, and ... , Now, the real question is, how do you ... secret? According to a study published by Child Development Journal, ... a dramatic effect on a child’s willingness to lend a ...
(Date:11/27/2014)... 27, 2014 At The Little Gym, ... it came as no surprise when a recent study ... academic success. The Journal of Pediatrics found ... motor tasks during the school years may be important ... development.” The study monitored two groups of children; those ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. "Every ... as we enjoy the ugly sweater contest." Last year's ... " It was a sight to see. She glued ... the Christmas balls were faces of the staff with Dr. ... this year, it's simple to get in on the fun. ...
Breaking Medicine News(10 mins):Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3
(Date:11/26/2014)... 26, 2014  Cohen, Placitella & Roth, PC ... who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") ... from January 31, 2011 through November 2, 2014 ... certain of its officers and directors publically disseminated ... Sections 10(b) and 20(a) of the Securities Exchange ...
(Date:11/26/2014)... , Nov. 26, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... U.S. Food and Drug Administration (FDA) has issued ... Application (NDA) for AVP-825. AVP-825 is an investigational ... delivered intranasally utilizing a novel Breath Powered delivery ... letter, and consistent with the preliminary feedback announced ...
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the Bank ... , , , Date: , , , Wednesday, December ... 2:50 p.m. EST , , , , Location: , , ... About BioScrip, Inc. BioScrip, Inc. ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
Cached News: